Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 6, 2026
First-in-Human Study of IL15-Activated Cytokine-Induced Killer Cells After Allogeneic HCT Shows Durable Remission and Serotherapy-Associated Immune Reconstitution in Leukemia
Eva Rettinger, Dirk Heckl, Martin Hutter, et al.
Leukemia
|
November 3, 2021
Correction: Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia
Arnold Kloos, Konstantinos Mintzas, Lina Winckler, et al.
Blood
|
March 15, 2013
Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-α in a murine model of polycythemia vera
Ann Mullally, Claudia Bruedigam, Luke Poveromo, et al.
Blood
|
September 27, 2021
The megakaryocytic transcription factor ARID3A suppresses leukemia pathogenesis
Oriol Alejo-Valle, Karoline Weigert, Raj Bhayadia, et al.
Cancer Letters
|
April 29, 2025
Using a novel panel of drug-resistant triple-negative breast cancer cell lines to identify candidate therapeutic targets and biomarkers
Helen E Grimsley, Magdalena Antczak, Ian G Reddin, et al.
Cell Stem Cell
|
August 4, 2018
Gli1<sup>+</sup> Mesenchymal Stromal Cells Are a Key Driver of Bone Marrow Fibrosis and an Important Cellular Therapeutic Target
Rebekka K Schneider, Ann Mullally, Aurelien Dugourd, et al.
Cell
|
April 9, 2016
Core Circadian Clock Genes Regulate Leukemia Stem Cells in AML
Rishi V Puram, Monika S Kowalczyk, Carl G de Boer, et al.
Cell Stem Cell
|
May 2, 2017
Gli1<sup>+</sup> Mesenchymal Stromal Cells Are a Key Driver of Bone Marrow Fibrosis and an Important Cellular Therapeutic Target
Rebekka K Schneider, Ann Mullally, Aurelien Dugourd, et al.
Blood Advances
|
April 7, 2026
DLK1 is a GATA1s-Driven Dependency and Therapeutic Target in Down Syndrome-Associated Myeloid Leukemia
Lonneke Verboon, Sonali P Barwe, Meredith Tavenner, et al.
Nature Communications
|
August 11, 2017
The non-coding RNA landscape of human hematopoiesis and leukemia
Adrian Schwarzer, Stephan Emmrich, Franziska Schmidt, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 6, 2026
First-in-Human Study of IL15-Activated Cytokine-Induced Killer Cells After Allogeneic HCT Shows Durable Remission and Serotherapy-Associated Immune Reconstitution in Leukemia
Eva Rettinger, Dirk Heckl, Martin Hutter, et al.
Leukemia
|
November 3, 2021
Correction: Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia
Arnold Kloos, Konstantinos Mintzas, Lina Winckler, et al.
Blood
|
March 15, 2013
Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-α in a murine model of polycythemia vera
Ann Mullally, Claudia Bruedigam, Luke Poveromo, et al.
Blood
|
September 27, 2021
The megakaryocytic transcription factor ARID3A suppresses leukemia pathogenesis
Oriol Alejo-Valle, Karoline Weigert, Raj Bhayadia, et al.
Cancer Letters
|
April 29, 2025
Using a novel panel of drug-resistant triple-negative breast cancer cell lines to identify candidate therapeutic targets and biomarkers
Helen E Grimsley, Magdalena Antczak, Ian G Reddin, et al.
Cell Stem Cell
|
August 4, 2018
Gli1<sup>+</sup> Mesenchymal Stromal Cells Are a Key Driver of Bone Marrow Fibrosis and an Important Cellular Therapeutic Target
Rebekka K Schneider, Ann Mullally, Aurelien Dugourd, et al.
Cell
|
April 9, 2016
Core Circadian Clock Genes Regulate Leukemia Stem Cells in AML
Rishi V Puram, Monika S Kowalczyk, Carl G de Boer, et al.
Cell Stem Cell
|
May 2, 2017
Gli1<sup>+</sup> Mesenchymal Stromal Cells Are a Key Driver of Bone Marrow Fibrosis and an Important Cellular Therapeutic Target
Rebekka K Schneider, Ann Mullally, Aurelien Dugourd, et al.
Blood Advances
|
April 7, 2026
DLK1 is a GATA1s-Driven Dependency and Therapeutic Target in Down Syndrome-Associated Myeloid Leukemia
Lonneke Verboon, Sonali P Barwe, Meredith Tavenner, et al.
Nature Communications
|
August 11, 2017
The non-coding RNA landscape of human hematopoiesis and leukemia
Adrian Schwarzer, Stephan Emmrich, Franziska Schmidt, et al.
Page
of 6